Yocaly’s iHolter got network license for telecommunication equipment

　　Recently, Yocaly’s iHolter (XAB-M3AG) successfully passed China Compulsory Certification and achieved network license for telecommunication equipment. Yocaly as medical-grade heart remote real-time monitoring solutions provider once guided the development of heart remote real-time monitoring field.

　　Yocaly’s core technology product iHolter is the world’s first mobile network medical terminal integrating electrophysiological data acquisition analysis and mobile IP technology, and could be widely used in long-term heart remote real-time monitoring among social and hospitalized patients.

　　Up to now, Yocaly has achieved 8 patent authorizations in China, American, Australia, Korean etc. and much software copyright. It also has passed the standard attestation of ISO9001 International Quality System for its ECG data analyzing service, and ISO13485 International Quality System for its remote heart monitoring system.

　　This time Yocaly achieved China Compulsory Certification and network license, opening new page in cardiovascular mobile medical field by comprehensive abilities of Yocaly’s product technology.

　　Re. network license for telecommunication equipment

　　“Network license for telecommunication equipment” consists of all the indispensible license entering into telecommunication market in China related with telecommunication terminal device. All the telecommunication devices must obtain network license issued by the Ministry of information industry. All the devices without network license couldn’t be used in public telecommunication network and domestic sales.

　　Re. Yocaly

　　As leading company in heart mobile medical field, Yocaly has owned over 350 hospitals, including Chinese PLA General Hospital, Beijing Anzhen Hospital, Qilu Hospital of Shandong University, Jiangxi People’s Hospital, Sichuan People’s Hospital, Wuhan Asia Cardiovascular Hospital, Shanghai First People's Hospital, and Shanghai Dongfang Hospital. In recent years, Yocaly has established strategic partnerships with eCardio, a famous cardiac monitoring service agency in US, ST group, one of the top 500 corporations, and Lepu Medical, the largest cardiovascular implantable device manufacturer in China, to jointly reduce incidence and mortality of acute cardiac events, improve patients’ living quality and prolong their lives.

　　Data cloud platform has stored 15,000,000 copies of medical-grade ECG data and, providing service for over 450,000 patients, early saving 22,481 cases of high-risk patients and saving their lives.